clofarabine

Details

Generic Name:

clofarabine

Project Status:

Not filed

Therapeutic Area:

Acute lymphoblastic leukemia

Manufacturer:

sanofi-aventis Canada Inc.

Brand Name:

Clolar

Project Line:

Reimbursement Review

Project Number:

N/A

Submission Type:

Non Submission

Indications:

For the treatment of pediatric patients 1 to 21 years old with relapsed or refractory acute lymphoblastic leukemia after at least two prior regimens.

Recommendation Type:

CADTH is unable to recommend reimbursement as a submission was not filed by the manufacturer

Last Updated : September 17, 2021